Related Experiment Videos
Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure
Hyun Ju Kim1, Nosratola D Vaziri
1Division of Nephrology and Hypertension, University of California, Irvine, California, USA.
Abstract:
Oxidative stress and inflammation are constant features and major mediators of progression of chronic kidney disease (CKD). Nuclear factor erythroid-2-related factor-2 (Nrf2) confers protection against tissue injury by orchestrating antioxidant and detoxification responses to oxidative and electrophilic stress. While sources of oxidative stress and inflammation in the remnant kidney have been extensively characterized, the effect of CKD on Nrf2 activation and expression of its downstream gene products is unknown and was investigated. Subgroups of male Sprague-Dawley rats were subjected to 5/6 nephrectomy or sham operation and observed for 6 or 12 wk. Kidneys were then harvested, and Nrf2 activity and its downstream target gene products (antioxidant and phase II enzymes) were assessed. In addition, key factors involved in promoting inflammation and oxidative stress were studied. In confirmation of earlier studies, rats with chronic renal failure exhibited increased lipid peroxidation, glutathione depletion, NF-kappaB activation, mononuclear cell infiltration, and upregulation of monocyte chemoattractant protein-1, NAD(P)H oxidase, cyclooxygenase-2, and 12-lipoxygenase in the remnant kidney pointing to oxidative stress and inflammation. Despite severe oxidative stress and inflammation, remnant kidney tissue Nrf2 activity (nuclear translocation) was mildly reduced at 6 wk and markedly reduced at 12 wk, whereas the Nrf2 repressor Keap1 was upregulated and the products of Nrf2 target genes [catalase, superoxide dismutase, glutathione peroxidase, heme oxygenase-1, NAD(P)H quinone oxidoreductase, and glutamate-cysteine ligase] were reduced or unchanged at 6 wk and significantly diminished at 12 wk. Thus oxidative stress and inflammation in the remnant kidney are compounded by conspicuous impairment of Nrf2 activation and consequent downregulation of the antioxidant enzymes.
Insights
Chronic kidney disease (CKD) worsens oxidative stress and inflammation. In CKD, the protective Nuclear factor erythroid-2-related factor-2 (Nrf2) pathway is impaired, reducing antioxidant defenses.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Oxidative stress and inflammation are key drivers in chronic kidney disease (CKD) progression.
- Nuclear factor erythroid-2-related factor-2 (Nrf2) is a crucial regulator of cellular defense against oxidative and electrophilic stress.
Purpose of the Study:
- To investigate the impact of CKD on Nrf2 activation and its downstream antioxidant gene products in the remnant kidney.
- To assess the relationship between oxidative stress, inflammation, and Nrf2 pathway function in a rat model of CKD.
Main Methods:
- A 5/6 nephrectomy rat model was used to induce CKD.
- Kidney tissues were analyzed for Nrf2 activity, its repressor Keap1, and downstream antioxidant/phase II enzyme products.
- Markers of oxidative stress (lipid peroxidation, glutathione levels) and inflammation (NF-kappaB, MCP-1, inflammatory enzymes) were quantified.
Main Results:
- CKD rats showed increased oxidative stress and inflammation, including elevated lipid peroxidation, NF-kappaB activation, and inflammatory mediators.
- Nrf2 activity (nuclear translocation) was significantly reduced in the remnant kidney at 6 and 12 weeks post-nephrectomy.
- Expression of Nrf2 target genes (e.g., catalase, SOD, HO-1) was diminished, while the Nrf2 repressor Keap1 was upregulated.
Conclusions:
- CKD is associated with a marked impairment of Nrf2 activation in the remnant kidney.
- This Nrf2 dysfunction leads to the downregulation of crucial antioxidant and detoxification enzymes, exacerbating oxidative stress and inflammation in CKD.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Kidney Disease III: Interprofessional Care